Published in Radiat Res on May 01, 1976
Estimation of α/β for late rectal toxicity based on RTOG 94-06. Int J Radiat Oncol Biol Phys (2011) 2.96
The tumor radiobiology of SRS and SBRT: are more than the 5 Rs involved? Int J Radiat Oncol Biol Phys (2014) 2.28
21 years of biologically effective dose. Br J Radiol (2010) 2.22
The linear-quadratic model is an appropriate methodology for determining isoeffective doses at large doses per fraction. Semin Radiat Oncol (2008) 1.74
Hypofractionation for prostate cancer. Cancer J (2009) 1.21
Rationale, conduct, and outcome using hypofractionated radiotherapy in prostate cancer. Semin Radiat Oncol (2008) 1.04
Radiosensitization by misonidazole (Ro-07-0582) of fractionated X-rays in a murine tumour. Br J Cancer Suppl (1978) 1.02
Tissue repair capacity and repair kinetics deduced from multifractionated or continuous irradiation regimens with incomplete repair. Br J Cancer Suppl (1984) 1.00
Skin sensitization by misonidazole: a demonstration of uniform mild hypoxia. Br J Cancer (1982) 0.96
The first James Kirk memorial lecture. What next in fractionated radiotherapy? Br J Cancer Suppl (1984) 0.94
Clinical development of new drug-radiotherapy combinations. Nat Rev Clin Oncol (2016) 0.91
Radiation-induced damage in the central nervous system: an interpretation of target cell responses. Br J Cancer Suppl (1986) 0.89
Vasculotide, an Angiopoietin-1 mimetic, reduces acute skin ionizing radiation damage in a preclinical mouse model. BMC Cancer (2014) 0.84
Stereotactic body radiotherapy treatment of extracranial metastases. Nat Rev Clin Oncol (2012) 0.84
Modern Radiotherapy Concepts and the Impact of Radiation on Immune Activation. Front Oncol (2016) 0.83
Radiobiology of radiosurgery for the central nervous system. Biomed Res Int (2013) 0.83
Effects of local hyperthermia on the pharmacokinetics of misonidazole in the anaesthetized mouse. Br J Cancer (1980) 0.83
The relationship between functional assays of radiation response in the lung and target cell depletion. Br J Cancer Suppl (1986) 0.82
Track-event theory of cell survival with second-order repair. Radiat Environ Biophys (2015) 0.82
Interaction of radiosensitizers and WR-2721. I. Modification of skin radioprotection. Br J Cancer (1982) 0.81
Inhibition of MDM2 by RG7388 confers hypersensitivity to X-radiation in xenograft models of childhood sarcoma. Pediatr Blood Cancer (2015) 0.81
An evaluation of dose equivalence between synchrotron microbeam radiation therapy and conventional broad beam radiation using clonogenic and cell impedance assays. PLoS One (2014) 0.80
Immune reaction induced by X-rays and pions and its stimulation by schizophyllan (SPG). Br J Cancer Suppl (1996) 0.80
Primary Treatment Options for High-Risk/Medically Inoperable Early Stage NSCLC Patients. Clin Lung Cancer (2015) 0.80
The effect of small radiation doses on mouse skin. Br J Cancer Suppl (1986) 0.79
Discussions on target theory: past and present. J Radiat Res (2013) 0.78
Accuracy of RBE: experimental and theoretical considerations. Radiat Environ Biophys (2010) 0.76
RAD51 Is a Selective DNA Repair Target to Radiosensitize Glioma Stem Cells. Stem Cell Reports (2017) 0.75
A local effect model-based interpolation framework for experimental nanoparticle radiosensitisation data. Cancer Nanotechnol (2017) 0.75
The effect of pentoxifylline on radiobiological parameters in the rat radiation myelopathy. Cancer Res Treat (2006) 0.75
Relationship of functional changes and radiation induced cardiomyopathy in dogs. Br J Cancer Suppl (1986) 0.75
The probabilities of one- and multi-track events for modeling radiation-induced cell kill. Radiat Environ Biophys (2017) 0.75
The number of patients required in a clinical trial. Br J Radiol (1971) 3.85
A simple analytic derivation suggests that prostate cancer alpha/beta ratio is low. Int J Radiat Oncol Biol Phys (2001) 2.67
Radiosensitizers of hypoxic cells in solid tumors. Cancer Treat Rev (1976) 2.33
High dose rate intracavitary brachytherapy for carcinoma of the cervix: the Madison system: I. Clinical and radiobiological considerations. Int J Radiat Oncol Biol Phys (1992) 2.24
The adverse effect of treatment prolongation in cervical carcinoma. Int J Radiat Oncol Biol Phys (1995) 2.05
Idealized versus realized overall treatment times. Int J Radiat Oncol Biol Phys (1994) 2.02
Cell kinetic measurements in prostate cancer. Int J Radiat Oncol Biol Phys (1997) 1.83
Selective boosting of tumor subvolumes. Int J Radiat Oncol Biol Phys (2000) 1.68
Postoperative vaginal cuff irradiation using high dose rate remote afterloading: a phase II clinical protocol. Int J Radiat Oncol Biol Phys (1995) 1.64
North American Contact Dermatitis Group patch test results for the detection of delayed-type hypersensitivity to topical allergens. J Am Acad Dermatol (1998) 1.51
Balsam-related systemic contact dermatitis. J Am Acad Dermatol (2001) 1.50
Final report of the general clinical results of the British Institute of Radiology fractionation study of 3F/wk versus 5F/wk in radiotherapy of carcinoma of the laryngo-pharynx. Br J Radiol (1990) 1.48
Caution on the use of altered fractionation for nasopharyngeal carcinoma. Radiother Oncol (1999) 1.43
Alpha, beta, and surviving fraction. Int J Radiat Oncol Biol Phys (1992) 1.40
Peristomal allergic contact dermatitis due to Gantrez in Stomahesive paste. J Am Acad Dermatol (2000) 1.40
Re-analysis of the time factor in local control by radiotherapy of T3T4 squamous cell carcinoma of the larynx. Int J Radiat Oncol Biol Phys (1991) 1.38
Radiosensitization of C3H mouse mammary tumours by a 2-nitroimidazole drug. Br J Cancer (1974) 1.35
The effect of irradiating a transplanted murine lymphosarcoma on the subsequent development of metastases. Br J Cancer (1973) 1.33
A modelled comparison of the effects of using different ways to compensate for missed treatment days in radiotherapy. Clin Oncol (R Coll Radiol) (1996) 1.31
The effects of magnesium deficiency of ketamine sleeping times in the rat. Br J Anaesth (1975) 1.29
Effect of time, dose, and fractionation on temporal lobe necrosis following radiotherapy for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys (1998) 1.26
A murine model of lip epidermal/mucosal reactions to X-irradiation. Radiother Oncol (1983) 1.21
A review of alpha/beta ratios for experimental tumors: implications for clinical studies of altered fractionation. Int J Radiat Oncol Biol Phys (1985) 1.18
Optimum fractionation of the C3H mouse mammary carcinoma using x-rays, the hypoxic-cell radiosensitizer Ro-07-0582, or fast neutrons. Int J Radiat Oncol Biol Phys (1977) 1.16
Changes in mouse blood pressure, tumor blood flow, and core and tumor temperatures following nembutal or urethane anesthesia. Radiology (1976) 1.15
Non-small cell lung tumors repopulate rapidly during radiation therapy. Int J Radiat Oncol Biol Phys (2000) 1.14
Repair in mouse lung between multiple small doses of X rays. Radiat Res (1983) 1.09
Biological properties and response to x-rays of first-generation transplants of spontaneous mammary carcinomas in C3H mice. Int J Radiat Biol Relat Stud Phys Chem Med (1975) 1.09
Summary of general discussion on radiotherapeutic aspects of the clinical application of fast neutrons. Eur J Cancer (1971) 1.08
Fractionation factors for late effects in head and neck cancers. Int J Radiat Oncol Biol Phys (1992) 1.07
Review: total doses in fractionated radiotherapy--implications of new radiobiological data. Int J Radiat Biol Relat Stud Phys Chem Med (1984) 1.06
The incidence of lung metastases in C3H mice after treatment of implanted solid tumours with x-rays or surgery. Br J Cancer (1974) 1.05
Vascular targeting of solid tumours: a major 'inverse' volume-response relationship following combretastatin A-4 phosphate treatment of rat rhabdomyosarcomas. Eur J Cancer (2000) 1.04
Current aspects of radiobiology as applied to radiotherapy. Clin Radiol (1972) 1.03
Skin reactions in mice after multifraction x-irradiation. Int J Radiat Biol Relat Stud Phys Chem Med (1974) 1.03
Hypoxic cell sensitisers in radiotherapy. Lancet (1976) 1.03
Radiosensitization by misonidazole (Ro-07-0582) of fractionated X-rays in a murine tumour. Br J Cancer Suppl (1978) 1.02
High dose rate intracavitary brachytherapy for carcinoma of the cervix: the Madison system: II. Procedural and physical considerations. Int J Radiat Oncol Biol Phys (1992) 1.02
Dose-response relationships for human tumors: implications for clinical trials of dose modifying agents. Int J Radiat Oncol Biol Phys (1984) 1.01
Confirmation of improved local-regional control with altered fractionation in head and neck cancer. Int J Radiat Oncol Biol Phys (2000) 1.01
Application of robotic stereotactic radiotherapy to peripheral stage I non-small cell lung cancer with curative intent. Clin Oncol (R Coll Radiol) (2009) 0.99
The prediction of late rectal complications in patients treated with high dose-rate brachytherapy for carcinoma of the cervix. Int J Radiat Oncol Biol Phys (1997) 0.99
The measurement of blood perfusion in experimental tumors by uptake of 86Rb. Cancer Res (1974) 0.98
Radiosensitizing and cytocidal effects on hypoxic cells of RO-07-0582, and repair of x-ray injury, in an experimental mouse tumour. Br J Cancer (1977) 0.97
A review of hypoxic cell radiosensitization in experimental tumors. Pharmacol Ther (1979) 0.97
A drug for improved radiosensitization in radiotherapy. Br J Cancer (1980) 0.96
The effect of overall treatment time in radiotherapy for localized prostate carcinoma. Int J Radiat Oncol Biol Phys (1991) 0.96
Repair in mouse lung for up to 20 fractions of X rays or neutrons. Br J Radiol (1985) 0.96
WR-2721 protection of pneumonitis and fibrosis in mouse lung after single doses of x rays. Int J Radiat Oncol Biol Phys (1984) 0.95
Potential for increasing the differential response between tumors and normal tissues: can proliferation rate be used? Int J Radiat Oncol Biol Phys (1986) 0.95
Radiosensitization of C3H mouse mammary tumours using fractionated doses of x rays with the drug Ro-07-0582. Br J Radiol (1976) 0.95
Sustained progression-free survival with weekly paclitaxel and bevacizumab in recurrent ovarian cancer. Gynecol Oncol (2009) 0.94
The first James Kirk memorial lecture. What next in fractionated radiotherapy? Br J Cancer Suppl (1984) 0.94
Radiosensitization of solid tumors by nitroimidazoles. Int J Radiat Oncol Biol Phys (1978) 0.94
Exit doses for lung fields measured by lithium fluoride thermoluminescence. Br J Radiol (1965) 0.93
A new incomplete-repair model based on a 'reciprocal-time' pattern of sublethal damage repair. Acta Oncol (1999) 0.93
Optimum fractionation in X-ray treatment of C3H mouse mammary tumours. Br J Radiol (1974) 0.93
The effect of anaesthetics on blood perfusion in transplanted mouse tumours. Br J Cancer (1975) 0.93
Fifth progress report on the British Institute of Radiology fractionation trial of 3F-week or 5F-week treatment of larynx and pharynx. Br J Radiol (1972) 0.92
Cell population kinetics of plucked and unplucked mouse skin. I. Unirradiated skin. Cell Tissue Kinet (1973) 0.92
Fractionation with x rays and neutrons in mice: response of skin and C 3 H mammary tumours. Br J Radiol (1972) 0.91
The proportion of hypoxic cells in a human tumor. Int J Radiat Oncol Biol Phys (1978) 0.91
Is there a loss of repair capacity in mouse lungs with increasing numbers of dose fractions? Int J Radiat Oncol Biol Phys (1983) 0.91
Panniculitis associated with hepatitis. Cutis (1983) 0.91
Linear-quadratic analysis of radiosensitization by halogenated pyrimidines. I. Radiosensitization of human colon cancer cells by iododeoxyuridine. Radiat Res (1992) 0.90
Letter: A rapid method for the determination of tumour RBE. Br J Radiol (1974) 0.90
Kinetics of cell labeling and thymidine replacement after continuous infusion of halogenated pyrimidines in vivo. Int J Radiat Oncol Biol Phys (1994) 0.90
Experimental animal results relating to time-dose relationships in radiotherapy and the "ret" concept. Br J Radiol (1971) 0.89
Predicting realistic RBE values for clinically relevant radiotherapy schedules. Int J Radiat Biol (1997) 0.89
Serologic and clinical features of patients with discoid lupus erythematosus: relationship of antibodies to single-stranded deoxyribonucleic acid and of other antinuclear antibody subsets to clinical manifestations. J Am Acad Dermatol (1985) 0.88
Early and late injuries in mouse rectum after fractionated X-ray and neutron irradiation. Radiother Oncol (1993) 0.88
Biologically effective doses in medium dose rate brachytherapy of cancer of the cervix. Radiat Oncol Investig (1997) 0.88
Misonidazole in fractionated radiotherapy: are many small fractions best? Br J Radiol (1980) 0.88
Novel fractionation schemes and high linear energy transfer. Prog Exp Tumor Res (1984) 0.87
T1 nasopharyngeal carcinoma: the effect of waiting time on tumor control. Int J Radiat Oncol Biol Phys (1994) 0.87
Letter: Fractionation schedules and a quadratic dose-effect relationship. Br J Radiol (1975) 0.86
Cell population kinetics and desquamation skin reactions in plucked and unplucked mouse skin. II. Irradiated skin. Cell Tissue Kinet (1973) 0.86
Changes in 32P counting-rate in human and animal tumours. Br J Radiol (1968) 0.86
A comparison of the efficacy and complication rates of low dose-rate versus high dose-rate brachytherapy in the treatment of uterine cervical carcinoma. Int J Radiat Oncol Biol Phys (1994) 0.85
Dental metal allergy in patients with oral, cutaneous, and genital lichenoid reactions. Am J Contact Dermat (2001) 0.85
Effect of time, dose and fractionation on local control of nasopharyngeal carcinoma. Radiother Oncol (1995) 0.85
The second Klaas Breur memorial lecture. La Ronde--radiation sciences and medical radiology. Radiother Oncol (1983) 0.85
Urinary retention associated with herpes zoster infection. Int J Dermatol (1993) 0.84
Preclinical evaluation of pions in vivo: experience at TRIUMF. Radiother Oncol (1990) 0.84
The RBE for mouse skin irradiated with 3-MeV neutrons: single and fractionated doses. Radiat Res (1983) 0.84
Seventh interim progress report of the british institute of radiology fractionation study of 3F/week versus 5F/week in radiotherapy of the laryngo-pharynx. Br J Radiol (1982) 0.84
The response of mouse epidermis to fractionated doses of pi mesons. Int J Radiat Oncol Biol Phys (1987) 0.84
HLA antigens in lichen sclerosus et atrophicus. Arch Dermatol (1990) 0.84
Superfractionated radiotherapy in grade III, IV intracranial gliomas. Int J Radiat Oncol Biol Phys (1988) 0.84
Simultaneous contact allergy to neomycin, bacitracin, and polymyxin. J Am Acad Dermatol (1990) 0.83
Radiosensitization of a mouse tumour by Ro 03-8799: acute and protracted administration. Int J Radiat Biol Relat Stud Phys Chem Med (1983) 0.83
Dose fractionation schedules--biologic aspects and applications to high LET radiotherapy. J Can Assoc Radiol (1975) 0.83
Effect of hair plucking on the kinetics of methylcholanthrene-induced skin tumours in mice. Cell Tissue Kinet (1970) 0.83
Method of analysis to derive cell survival from observation of tissue damage following fractionated irradiation. Radiat Res (1979) 0.83
Is there a future for cell kinetic measurements using IdUrd or BdUrd? Int J Radiat Oncol Biol Phys (2001) 0.83
A helpful aid for pill swallowing: the pop-bottle method. Cutis (1986) 0.83
Radiotherapy employing three fractions on each of twelve consecutive days. Acta Oncol (1988) 0.83
Effect of cyclophosphamide or x-rays on spontaneously occurring metastases from tumors transplanted into the tails of mice. Cancer Res (1981) 0.83
Radiobiology of pions at TRIUMF. Int J Radiat Oncol Biol Phys (1982) 0.83